Oncology

‘Jumping gene’ helps explain elevated pancreatic cancer risk in French-Canadians

keila.depape@mcgill.ca — Tue, 19 May 2026 14:13:41 +0000

Researchers at 91ɬ�� have discovered a centuries-old genetic mutation that helps to explain why some French‑Canadians in Quebec are at an elevated risk of pancreatic cancer. Until quite recently, standard genetic tests have not been able to identify this “jumping gene” cause.

The findings, published in the Journal of Medical Genetics, suggest better-targeted genetic testing could help identify people at higher cancer risk who were previously missed.

Gerald Batist

frederique.mazerolle@mcgill.ca — Tue, 08 Dec 2020 21:10:24 +0000

Two 91ɬ�� professors lead new Stand Up to Cancer Canada Metastatic Breast Cancer Dream Team

laurie.devine@mcgill.ca — Fri, 09 Aug 2019 14:01:38 +0000

Marc Miller, Member of Parliament (Ville-Marie–Le Sud-Ouest–Île-des-Sœurs, Quebec) and Parliamentary Secretary to the Minister of Crown-Indigenous Relations, on behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, announced today at 91ɬ�� an investment of up to $6 million for a scientific task force of top researchers to develop new and improved approaches to cancer treatment and care. The funding will be distributed over four years to the new pan-Canadian program, the Stand Up to Cancer (SU2C) Canada Metastatic Breast Cancer Dream Team.

Michael Pollak